Furthermore, MMP inhibitor TIMP3, an ECM-related protein that exhibited higher protein expression in ND-AAA-SMCs than C-SMCs and D-AAA-SMCs in the proteomics analysis, showed a significant reduction in gene expression following metformin treatment (p = 0.005). Here, TIMP3 is linked to triple-A syndrome.